Andere Sprachen Aquestive Therapeutics, Inc.

Aktien

A2JQ4G

US03843E1047

AQST

Realtime-Estimate Cboe BZX Andere Börsenplätze 18:49:20 01.05.2024			% 5 Tage	% 1. Jan.
3,295 ^USD	-1,93 %		-15,61 %	+62,93 %

29.04.	Aquestive Therapeutics erhält FDA-Zulassung für Libervant zur Behandlung von Krampfanfällen bei Kindern	MT
29.04.	Transcript : Aquestive Therapeutics, Inc. - Special Call

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Aquestive Therapeutics Obtains FDA Approval for Libervant to Treat Seizure in Children	29.04.
Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film	29.04.
Aquestive Therapeutics, Inc Receives U.S. FDA Approval and Market Access for Libervant? Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm? (epinephrine) Sublingual Film	29.04.
Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET	25.04.
Aquestive Therapeutics to Present Crossover Study Data for Libervant Buccal Film at 76th Annual Meeting of the American Academy of Neurology	15.04.
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology	12.04.
Aquestive Therapeutics, Inc. to Present Crossover Study Data for Libervant Buccal Film At 76th Annual Meeting of the American Academy of Neurology	12.04.
Aquestive Therapeutics Files $250 Million Mixed Shelf	03.04.
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive	01.04.
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive	01.04.
Aquestive Therapeutics, Inc. Appoints Abigail Jenkins to Board of Directors, Effective April 1, 2024	01.04.
Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock	25.03.
Top Midday Decliners	20.03.
Sector Update: Health Care Stocks Steady Premarket Wednesday	20.03.
Wall Street Set to Open Flat as Investors Look Toward Fed Decision; Oil Prices Drop Sharply	20.03.
Top Premarket Decliners	20.03.
Aquestive Therapeutics Prices $75 Million Common Stock Offering; Shares Slump Premarket	20.03.
Aquestive Therapeutics Prices $75 Million Common Stock Offering	20.03.
Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock	20.03.
Aquestive Therapeutics Proposes Public Stock Offering -- Shares Drop	19.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Aquestive Therapeutics, Inc.

Aktien

A2JQ4G

US03843E1047

AQST

Andere Sprachen

Filter